Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arix Bioscience
Biotech
Arix cuts costs, changes leadership team to hunker down
Naseem Amin, formerly of Biogen, is stepping up to the executive chairman position to lead the biotech investor through a potentially tricky period.
Nick Paul Taylor
Apr 10, 2020 8:11am
Quench Bio emerges with $50M to treat inflammatory diseases
Jan 27, 2020 2:00am
Autolus drags on Arix after weak period for CAR-T player
Aug 28, 2019 8:21am
Imara lands $63M crossover round to trial sickle cell drug
Mar 18, 2019 10:47am
Enzyvant finds new CEO in former Alexion exec—Chutes & Ladders
Feb 22, 2019 9:00am
Arix reappoints CEO 5 months after starting hunt for replacement
Feb 19, 2019 10:15am
